These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8547630)

  • 21. Monoclonal antibody against myeloid leukemia cell line (KG-1).
    Aota F; Chang D; Hill NO; Khan A
    Cancer Res; 1983 Mar; 43(3):1093-6. PubMed ID: 6572095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues.
    Lin G; Finger E; Gutierrez-Ramos JC
    Eur J Immunol; 1995 Jun; 25(6):1508-16. PubMed ID: 7542195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally.
    Hidalgo A; Weiss LA; Frenette PS
    J Clin Invest; 2002 Aug; 110(4):559-69. PubMed ID: 12189250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion.
    Yoo ES; Lee KE; Seo JW; Yoo EH; Lee MA; Im SA; Mun YC; Lee SN; Huh JW; Kim MJ; Jo DY; Ahn JY; Lee SM; Chung WS; Kim JH; Seong CM
    Stem Cells; 2003; 21(2):228-35. PubMed ID: 12634419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
    Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K
    Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells.
    Wang MW; Consoli U; Lane CM; Durett A; Lauppe MJ; Champlin R; Andreeff M; Deisseroth AB
    Cell Growth Differ; 1998 Feb; 9(2):105-12. PubMed ID: 9486846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to CD44 enhance adhesion of normal CD34+ cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma.
    Bendall LJ; Kirkness J; Hutchinson A; Bianchi A; Makrynikola V; Bradstock KF; Gottlieb DJ
    Br J Haematol; 1997 Sep; 98(4):828-37. PubMed ID: 9326174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
    Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
    Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34.
    Astall E; Yarranton H; Arno J; Marcus R
    J Clin Pathol; 1999 Sep; 52(9):705-7. PubMed ID: 10655997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins.
    Sassetti C; Van Zante A; Rosen SD
    J Biol Chem; 2000 Mar; 275(12):9001-10. PubMed ID: 10722749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular identity of hematopoietic precursor cells emerging in the human embryo.
    Labastie MC; Cortés F; Roméo PH; Dulac C; Péault B
    Blood; 1998 Nov; 92(10):3624-35. PubMed ID: 9808556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.
    Zannettino AC; Bühring HJ; Niutta S; Watt SM; Benton MA; Simmons PJ
    Blood; 1998 Oct; 92(8):2613-28. PubMed ID: 9763543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.
    Watt SM; Williamson J; Genevier H; Fawcett J; Simmons DL; Hatzfeld A; Nesbitt SA; Coombe DR
    Blood; 1993 Nov; 82(9):2649-63. PubMed ID: 7693043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
    Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
    Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers.
    Matsui H; Takeshita A; Naito K; Shinjo K; Shigeno K; Maekawa M; Yamakawa Y; Tanimoto M; Kobayashi M; Ohnishi K; Ohno R
    Leukemia; 2002 May; 16(5):813-9. PubMed ID: 11986941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous or modulation expression of hematopoietic cell antigens in sublines of the leukemia cell line, K-562.
    Ichiki AT; Lozzio CB; Bamberger EG; Lucas PB; Wust CJ; Fuhr JE
    Leuk Res; 1987; 11(4):359-64. PubMed ID: 3470580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.